| 1 | Ordinary | Adoption of standalone and consolidated financial statements for the year ended 31 March 2022 |  |
| 2 | Ordinary | Declare final dividend of Rs. 2.25 per equity share (including special dividend of Rs. 0.75) of face value of Rs. 2.0 for FY22 | |
| 3 | Ordinary | Reappoint Dr. Anand M Nadkarni (DIN: 06881461) as Non-Executive Non-Independent Director, liable to retire by rotation | |
| 4 | Ordinary | Reappoint Gokhale & Sathe as statutory auditors from the conclusion of 2022 AGM till the conclusion of 2027 AGM and fix their remuneration for FY23 | |
| 5 | Special | Reappoint Ms. Aditi Kare Panandikar (DIN: 00179113) as Managing Director for five years from 15 February 2022 and fix her remuneration as minimum remuneration in excess of regulatory thresholds |  |
| 6 | Special | Reappoint Sundeep V Bambolkar (DIN: 00176613) as Joint Managing Director for five years from 15 February 2022 and fix his remuneration as minimum remuneration | |
| 7 | Special | Approve of Indoco Remedies Employee Stock Option Plan – 2022 (ESOP 2022) under which 9,21,504 stock options and 460,752 Restricted Stock Units (RSUs) can be granted | |
| 8 | Special | Approve grant of options/ RSUs under Indoco Remedies Employee Stock Option Plan – 2022 (ESOP 2022) to employees of subsidiary companies | |
| 9 | Special | Approve provision of money to Indoco Employees Welfare Trust to implement Employee Stock Option Plan – 2022 (ESOP 2022) | |
| 10 | Ordinary | Ratify remuneration of Rs. 180,000 payable to Joshi Apte and Associates as cost auditors for FY23 | |
| 11 | Ordinary | Approve Ms. Madhura Ramani in office of profit from 1 June 2022 at a maximum remuneration of Rs. 10 mn per annum (excluding allowances and reimbursements) | |
Sept. 22, 2022, 10:30 a.m.